Full name
IPSEN POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
58.1 - Publishing of books, newspapers, and periodicals, and other publishing activities, excluding software publishing
66.1 - Activities supporting financial services, excluding insurance and pension funds
70.10.Z - Head office activities
70.2 - Business and management consultancy activities
72.19.Z - Scientific research and development activities
73.1 - Advertising
73.20.Z - Market research and public opinion polling
82.9 - Other business support activities, not elsewhere classified
85 - Education
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,7 | 6,3 | 8,4 | 33,3 |
EBITDA | 0,5 | 5,2 | 7 | 32,9 |
Short time liabilities | 100,9 | 139,9 | 160,9 | 15,1 |
Equity capital | 14,9 | 19,8 | 26,3 | 33 |
Operating profit (EBIT) | 2,1 | 6,2 | 7,2 | 16,4 |
Assets | 133,8 | 177,6 | 210,5 | 18,5 |
Net profit (loss) | 1,2 | 4,9 | 6,5 | 33,6 |
Cash | 11,1 | 14,4 | 21,9 | 51,8 |
Net income from sale | 250,4 | 288,7 | 348 | 20,6 |
Liabilities and provisions for liabilities | 118,9 | 157,9 | 184,2 | 16,7 |
Working assets | 118,7 | 173 | 206,8 | 19,5 |
Depreciation | -1,7 | -1 | -0,3 | 72,6 |
% | % | % | p.p. | |
Profitability of capital | 8 | 24,7 | 24,8 | 0,1 |
Equity capital to total assets | 11,1 | 11,1 | 12,5 | 1,4 |
Gross profit margin | 0,7 | 2,2 | 2,4 | 0,2 |
EBITDA Margin | 0,2 | 1,8 | 2 | 0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 147 | 177 | 169 | -8 |
Current financial liquidity indicator | 1.0861408710479736 | 1.1285419464111328 | 1.15142822265625 | 0,1 |
Net dept to EBITDA | -1.0591888427734375 | -2.7535693645477295 | -3.1458349227905273 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane